EVEREST MEDICINES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.85 HKD | -3.25% |
|
+2.14% | +14.11% |
| 25/04 | Everest Medicines' Loss Widens in 2023 | MT |
| 28/03 | Everest Medicines Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Everest Medicines Limited
cde7cc.JUxD3DsFWtOEKB8-bxfmvdaG5nzieXsLvc6L4HAi_7I.HBkVtXZjI6vUHEdvKiGp9rnqgCSVQAFp1avnozkauYNRDReTDmFuuMlDfA~8e75072987f899ac5ddb8f043a1bfe03
Upcoming events on Everest Medicines Limited
Past events on Everest Medicines Limited
| 28/03/2024 06:30 am | Q4 2023 Earnings Call |
| 28/03/2024 | Q4 2023 Earnings Release |
| 28/11/2023 | Evercore ISI HealthCONx Conference |
| 27/11/2023 06:30 pm | Nefecon Approval Call |
| 27/11/2023 | BOCOM International Corporate Day |
| 03/11/2023 06:30 am | American Society of Nephrology Kidney Conference |
| 02/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Abstract 3969868 |
| 12/09/2023 | Morgan Stanley Global Healthcare Conference |
| 12/09/2023 | Goldman Sachs China Conference |
| 11/09/2023 | H.C.W Global Investment Conference |
| 24/08/2023 06:30 am | Q2 2023 Earnings Call |
| 24/08/2023 | Q2 2023 Earnings Release |
| 31/03/2023 06:30 am | Q4 2022 Earnings Call |
| 30/03/2023 | Q4 2022 Earnings Release |
| 10/01/2023 | Citi China Healthcare Corporate Day |
| 04/01/2023 | Morgan Stanley Virtual China Opportunity Conference |
| 03/01/2023 05:30 pm | Business Update Call |
| 01/12/2022 | Western Securities Investment Strategy Conference |
| 15/11/2022 | Goldman Sachs Asia Pacific Healthcare Forum |
| 07/11/2022 | Credit Suisse Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,05 1,92 -97.18% | 12,8 1 261 -98.99% | 126 101 24.54% | 673 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | -668 -456 -46.64% | -995 -816 -22% | -214 -4,62 -4531.24% | 0,00 -767 - | -450 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -688 -464 -48.22% | -1 054 -1 107 4.8% | -257 -36,5 -603.23% | -933 -941 0.9% | -649 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -5 658 -426 -1228.8% | -1 009 -1 054 4.34% | -247 272 -190.89% | -844 -916 7.84% | -623 |
|
Net income Million CNY | Released Forecast Spread | -215 | -5 658 -320 -1669.4% | -1 009 -1 046 3.57% | -247 50,4 -591.11% | -844 -916 7.84% | -623 |
|
EPS CNY | Released Forecast Spread | -41,0 | -66,3 -5,01 -1223.57% | -3,44 -3,64 5.42% | -0,83 0,08 -1093.65% | 0,00 -3,01 - | -1,99 |
| Announcement Date | 20/09/20 | 22/03/21 | 28/03/22 | 30/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,05 0,00 - | 1,04 12,8 -91.86% | 11,8 1 950 -99.4% | 8,90 14,4 -38.35% | 116 | 253 | 460 |
|
EBIT Million CNY | Released Forecast Spread | -406 -441 7.88% | -654 -1 250 47.67% | -640 -556 -15.11% | 383 1 241 -69.16% | -631 | -583 | -340 | -295 | ||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 421 1 252 -66.4% | |||||||||
|
Net income Million CNY | Released Forecast Spread | 421 1 064 -60.47% | |||||||||
|
EPS CNY | Released Forecast Spread | -1,31 -1,34 2.24% | -2,13 -4,07 47.67% | -2,26 -1,85 -22.16% | 1,43 2,18 -34.25% | -2,11 | -1,74 | -1,01 | -0,83 | ||
| Announcement Date | - | 22/03/21 | 30/08/21 | 28/03/22 | 24/08/22 | 30/03/23 | 24/08/23 | - | - | - |
More events
Past sector events for Everest Medicines Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1952 Stock
- Calendar Everest Medicines Limited
